(Q34446855)

2 August 2017

Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins (English)

1 reference

2 August 2017

Lehtonen A

1

1 reference

2 August 2017

Himanen P

2

1 reference

2 August 2017

Saraste M

3

1 reference

2 August 2017

Niittymäki K

4

1 reference

2 August 2017

Marniemi J

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

21 Suppl 1

1 reference

2 August 2017

77S-81S

1 reference

Effect of pindolol on serum lipids and lipid metabolizing enzymes

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

Classification of hyperlipidaemias and hyperlipoproteinaemias

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

A long-term double-blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

Increase in serum-lipids during treatment of hypertension with chlorthalidone

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

Beta-blockers and plasma triglycerides.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400756

Long-term Effect of Sotalol on Plasma Lipids

28 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02857.X

Effect of propranolol and prazosin on blood lipids. The Oslo Study

21 January 2018

1 reference

12 December 2020

The effect of metoprolol and atenolol on plasma high density lipoprotein levels in man

1 reference

12 December 2020

Discriminative value of lipids and apoproteins in coronary heart disease

1 reference

12 December 2020

Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure

1 reference

12 December 2020

Atenolol and metoprolol: comparison of effects on blood pressure and serum lipoproteins, and side effects

1 reference

12 December 2020

Effect of atenolol on plasma HDL cholesterol subfractions

1 reference

12 December 2020

[Enzymatic determination of total cholesterol in serum (author's transl)]

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB02857.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference